Home > News > Amid Confusion, Nanotech Industry Awaits Boom
September 25th, 2007
Amid Confusion, Nanotech Industry Awaits Boom
Abstract:
What has been lacking is a wave of nanotech initial public offerings, which would herald the industry's arrival to investors. The disappointing pace of deals in the sector reflects problems in the IPO market, according to Mr. Harris, as much as the sometimes confusing evolution of nanotech products.
Last year only 56 venture capital-backed companies went public in America, down from 250 in 1999. Venture capital has been upstaged by private equity in recent years, in part because the latter sector has profited better from the liquid credit markets. Private equity deals have become increasingly leveraged and have consequently produced outsized returns for investors, while venture capital firms have traditionally been loath to add to the already risky nature of their investments by borrowing. Also, the huge and ultimately catastrophic boom in technology venture capital in the late 1990s left a distinctly sour taste in the public's mouth. Needless to say, the current seizing up of the credit markets could change the playing field.
Source:
nysun.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||